We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Centuri Holdings
CTRI
$2.1B
| $235K | ﹤0.01% |
+8,034
| New | +$234K |
2026 Q1
0 quarters
|
|
1402
ABM Industries
ABM
$2.97B
| $234K | ﹤0.01% |
6,067
+890
| +17% | +$38.5K |
2024 Q2
7 quarters
|
|
1403
Park National Corp
PRK
$3.17B
| $233K | ﹤0.01% |
+1,423
| New | +$233K |
2026 Q1
0 quarters
|
|
1404
Robert Half
RHI
$3.57B
| $232K | ﹤0.01% |
+9,142
| New | +$242K |
2026 Q1
0 quarters
|
|
1405
Calumet Specialty Products
CLMT
$5.15B
| $232K | ﹤0.01% |
+6,462
| New | +$167K |
2026 Q1
0 quarters
|
|
1406
Travere Therapeutics
TVTX
$4.88B
| $232K | ﹤0.01% |
7,807
-252
| -3% | -$7.53K |
2025 Q4
1 quarter
|
|
1407
Steven Madden
SHOO
$3.27B
| $231K | ﹤0.01% |
6,800
+1,128
| +20% | +$43.7K |
2025 Q4
1 quarter
|
|
1408
Adaptive Biotechnologies
ADPT
$4.03B
| $230K | ﹤0.01% |
16,572
+1,753
| +12% | +$27.9K |
2025 Q2
3 quarters
|
|
1409
DHT Holdings
DHT
$4.29B
| $230K | ﹤0.01% |
12,585
+2,065
| +20% | +$32.9K |
2025 Q4
1 quarter
|
|
1410
First Merchants
FRME
$2.45B
| $229K | ﹤0.01% |
+5,925
| New | +$231K |
2026 Q1
0 quarters
|
|
1411
WaFd
WAFD
$2.17B
| $229K | ﹤0.01% |
+7,308
| New | +$235K |
2026 Q1
0 quarters
|
|
1412
Dynex Capital
DX
$2.69B
| $229K | ﹤0.01% |
17,971
+6,458
| +56% | +$88.8K |
2025 Q3
2 quarters
|
|
1413
Vera Therapeutics
VERA
$1.93B
| $229K | ﹤0.01% |
5,689
+1,330
| +31% | +$57.3K |
2025 Q4
1 quarter
|
|
1414
ArcBest
ARCB
$2.91B
| $229K | ﹤0.01% |
+2,325
| New | +$220K |
2026 Q1
0 quarters
|
|
1415
Liquidia Corp
LQDA
$2.4B
| $228K | ﹤0.01% |
+6,046
| New | +$224K |
2026 Q1
0 quarters
|
|
1416
Perpetua Resources
PPTA
$2.42B
| $228K | ﹤0.01% |
+8,100
| New | +$245K |
2026 Q1
0 quarters
|
|
1417
SiriusPoint
SPNT
$2.93B
| $227K | ﹤0.01% |
+10,543
| New | +$217K |
2026 Q1
0 quarters
|
|
1418
St. Joe Company
JOE
$3.78B
| $227K | ﹤0.01% |
+3,612
| New | +$242K |
2026 Q1
0 quarters
|
|
1419
Privia Health
PRVA
$2.77B
| $227K | ﹤0.01% |
11,017
+1,837
| +20% | +$41.4K |
2025 Q2
3 quarters
|
|
1420
Perdoceo Education
PRDO
$2.11B
| $226K | ﹤0.01% |
+6,071
| New | +$201K |
2026 Q1
0 quarters
|
|
1421
First Hawaiian
FHB
$2.98B
| $226K | ﹤0.01% |
+9,167
| New | +$236K |
2026 Q1
0 quarters
|
|
1422
RXO
RXO
$4.72B
| $225K | ﹤0.01% |
15,362
+2,503
| +19% | +$36.7K |
2024 Q3
6 quarters
|
|
1423
Adient
ADNT
$1.39B
| $224K | ﹤0.01% |
11,098
+838
| +8% | +$18.6K |
2020 Q2
23 quarters
|
|
1424
Trustmark
TRMK
$2.59B
| $223K | ﹤0.01% |
+5,296
| New | +$223K |
2026 Q1
0 quarters
|
|
1425
Banc of California
BANC
$2.72B
| $223K | ﹤0.01% |
12,687
+2,588
| +26% | +$49.4K |
2025 Q1
4 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.